Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Interest Income Over TimeStrong
Percentile Rank83
3Y CAGR+106.9%
5Y CAGR+221.3%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+106.9%/yr
Annual compound
5Y CAGR
+221.3%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
342.2x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$23.61M-5.6%
2024$25.02M+76.3%
2023$14.19M+432.8%
2022$2.66M+562.7%
2021$402000.00+482.6%
2020$69000.00-68.5%
2019$219000.00-